Business Wire

MA-PROCTER-&-GAMBLE

11.2.2020 15:35:12 CET | Business Wire | Press release

Share
Gillette® and Twitch Announce the Return of the Gillette Gaming Alliance

Gillette (NYSE: PG), the world’s leading expert in men’s grooming, and Twitch, the leading service and community for multiplayer entertainment, today announced the return of the “Gillette Gaming Alliance ,” a team of five Twitch streamers from around the world that will collaborate with Gillette to create content for their fans. This is a continuation of a partnership that began in 2017.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200211005645/en/

Each of the Alliance members was selected to represent the brand and create customized content to engage with millions of viewers and fans worldwide. The Alliance consists of the biggest Twitch streamers: DrLupo , NateHill , DogDog , Alanzoka , and Elded .

In addition, members of the Gillette Gaming Alliance will support the “Bits for Blades” program, which provides fans the opportunity to earn Twitch Bits, a virtual good users can send in chat to support and cheer for their favorite streamers. To participate, Twitch users who buy Gillette products through Gillette.com will enter a unique promo code at check out and will receive an email code following their purchase to redeem their Twitch Bits. This year’s program brings a leveled-up value proposition for consumers, including 2,000 Twitch bits for $10+ spent, 5,000 Twitch bits for $25+ spent, and 10,000 Twitch bits for $50+ spent. Click to find out more here .

“Gillette is dedicated to providing the tools and support men need to bring their ‘A’ game each and every day,” said Gary Coombe, CEO of Gillette. “We are bringing this spirit to our partnership with Twitch by providing our Alliance members, players, and consumers with a world class grooming routine to help them face the challenges ahead with confidence.”

“It is truly an honor to partner with such a respected brand like Gillette,” said DrLupo. “I look forward to creating content with Gillette, collaborating with them on programs, and in the future working with them on charity streams. I have always admired Gillette and use their products daily, and they truly embody the same values as I do. I can’t wait to get started with the Alliance, Game On.”

Here is the full roster for the 2020 Gillette Gaming Alliance:

  • DrLupo: (Ben Lupo, USA)
    • DrLupo is a streamer and professional Fortnite player who has grown his Twitch community with his outgoing, friendly personality. He is a proponent of giving to charities and has held several charity streams in his tenure. He was named one of the most influential people on the internet by TIME magazine.
    • Twitch (3.5 Million Followers): https://www.twitch.tv/drlupo
  • NateHill (USA):
    • Model-turned pro-player Nate Hill is one of the best pro Fortnite players in the world. He helped FaZe Clan win the Fall Skirmish at TwitchCon 2018. His talents extend beyond gaming. He is a model, a former pro poker player, singer and musician. He is also part of the NFL Thursday Night Football co-streams on Twitch and recently played in the Twitch Rivals Streamer Bowl at the Super Bowl in Miami.
    • Twitch (768K Followers) : https://www.twitch.tv/natehill/
  • DogDog (USA):
    • DogDog is a professional Hearthstone player for Team Liquid and a top Hearthstone streamer. Known for his great attitude and instructional streams – DogDog has recently seen an explosion in viewership playing the new ‘TeamFight Tactics’ with his friends.
    • Twitch (583K Followers) : https://www.twitch.tv/dogdog/
  • Alanzoka (Brazil)
    • Alanzoka is a variety streamer from Brazil who is known for his sense of humor and high-skilled gameplay. He is a veteran creator on the Twitch platform, with one of the largest community followings.
    • Twitch (2.1 Million Followers): https://www.twitch.tv/alanzoka/
  • Elded (Mexico)
    • Elded is a well-known Spanish/English content creator, who has been with Twitch since 2009. He is a variety streamer with over 4.8 million subscribers across his social platforms.
    • Twitch (1.5 Million Followers) : https://www.twitch.tv/elded/

“We are honored to work with Gillette to bring back the Gillette Gaming Alliance,” adds Nathan Lindberg, Senior Director, Global Sponsorship at Twitch. “We are always looking for new and innovative ways to excite our viewers and fans while further supporting our streamers, and Gillette is the perfect partner for this! We are bringing Bits for Blades back in a bigger and better way in 2020, which is something we’re all very excited about.”

For more information, please visit Gillette’s official website here , and on Twitter and Facebook .

About Gillette

For more than 115 years, Gillette has delivered precision technology and unrivalled product performance – improving the lives of over 800 million consumers around the world. From shaving and body grooming, to skin care and sweat protection, Gillette offers a wide variety of products including razors, shave gel (gels, foams and creams), skin care, after shaves, antiperspirants, deodorants and body wash. For more information and the latest news on Gillette, visit www.gillette.com . To see our full selection of products, visit www.gillette.com . Follow Gillette on Twitter , Facebook and Instagram .

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

About Twitch:

Launched in 2011, Twitch is a global community that comes together each day to create multiplayer entertainment: unique, live, unpredictable experiences created by the interactions of millions. It brings the joy of co-op to everything, from casual gaming and world-class esports to anime marathons, music, and art streams. Twitch also hosts TwitchCon , the biggest community event of the year, where tens of thousands of people come together to celebrate and connect with others who share their interests and passions. We’re always live at Twitch . Stay up to date on all things Twitch on Twitter and on our Blog .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye